Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries

Journal of Interventional Cardiology

Volumn 21, Issue 2, 2008, Pages 122-128

  Waksman, Ron ^a   Pakala, Rajbabu ^a   Roy, Probal ^a   Baffour, Richard ^a   Hellinga, David ^a   Seabron, Rufus ^a   Chan, Rosanna ^a   Scheinowitz, Mickey ^a   Kolodgie, Frank ^b   Virmani, Renu ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CVPATH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG MECHANISM; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; INFLAMMATION; MACROPHAGES; MALE; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; RABBITS; TICLOPIDINE; TUNICA INTIMA;

EID: 41749106898     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2008.00347.x     Document Type: Article

References (44)

1. Schwartz RS, Holmes Jr. DR, Topol EJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992 20 : 1284 1293.
2. Fingerle J, Johnson R, Clowes AW, et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Nati Acad Sci USA 1989 86 : 8412 8416.
3. Le Breton H, Plow EF, Topol EJ. Role of platelets in restenosis after percutaneous coronary revacularization. J Am Coll Cardiol 1996 28 : 1643 1651.
4. Crowley ST, Dempsey EC, Horwitz KB, et al. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation 1994 90 : 1908 1918.
5. Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation 1997 96 : 2280 2286.
6. Anderson HV, McNatt J, Clubb FJ, et al. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolaemic atherosclerotic canine coronary arteries. Circulation 2001 104 : 2331 2337.
7. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003 23 : 2131 2137.
8. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998 391 : 591 594.
9. Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci USA 2000 97 : 7458 7463.
10. Rinder HM, Bonan JL, Rinder CS, et al. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991 78 : 1760 1769.
11. Neumann FJ, Zohlnhofer D, Fakhoury L, et al. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999 34 : 1420 1426.
12. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004 14 : 18 22.
13. Tanguay JF, Geoffroy P, Sirois MG, et al. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost 2004 91 : 1186 1193.
14. Phillips JW, Barringhaus KG, Sanders JM, et al. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 2003 107 : 2244 2249.
15. Silva MA, Donovan JL, Gandhi PJ, et al. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: Glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manag 2006 2 : 39 48.
16. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007 297 : 159 168.
17. Howard G, McClure LA, Krakauer JW, et al. Stroke and the statistics of the aspirin/clopidogrel secondary prevention trials. Curr Opin Neurol 2007 20 : 71 77.
18. Mannava K, Money SR. Current management of peripheral arterial occlusive disease: A review of pharmacologic agents and other interventions. Am J Cardiovasc Drugs 2007 7 : 59 66.
19. Foster CJ, Prosser DM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001 107 : 1591 1598.
20. Pakala R, Leborgne L, Cheneau E, et al. Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: A prospective vulnerable plaque model? Cardiovasc Radiat Med 2003 4 : 146 151.
21. Leborgne L, Fournadjiev J, Pakala R, et al. Antioxidants attenuate atherosclerotic plaque development in a balloon-denuded and -radiated hypercholesterolemic rabbit. Cardiovasc Radiat Med 2003 4 : 25 28.
22. Leborgne L, Pakala R, Dilcher C, et al. Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2005 46 : 540 547.
23. Pakala R, Dilcher C, Baffour R, et al. Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit. J Cardiovasc Pharmacol 2006 48 : 299 305.
24. Friedman RJ, Stemerman MB, Wenz B, et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest 1977 60 : 1191 1201.
25. Herbert JM, Tissinier A, Defreyn G, et al. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb 1993 13 : 1171 1179.
26. Cortelekoglu T, Bozkurt AK, Ustundag N, et al. The effects of clopidogrel and calcium dobesilate on intimal hyperplasia following vascular injury. Acta Chir Belg 2006 106 : 206 210.
27. Bledsoe SL, Brown AT, Davis JA, et al. Effect of clopidogrel on platelet aggregation and intimal hyperplasia following carotid endarterectomy in the rat. Vascular 2005 13 : 43 49.
28. Yamagami S, Miyauchi K, Kimura T, et al. Effects of the thromboxane A2 receptor antagonist on platelet deposition and intimal hyperplasia after balloon injury. Jpn Heart J 1999 40 : 791 802.
29. Cruz CP, Eidt J, Drouilhet J, et al. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 2001 34 : 724 729.
30. Umemura K, Nishiyama H, Kikuchi S, et al. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A, on intimal thickening in the guinea pig femoral artery. Thromb Haemost 1996 76 : 799 806.
31. Clowes AW, Karnovsky MJ. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Lab Invest 1977 36 : 452 464.
32. Radic ZS, O'Malley MK, Mikat EM, et al. The role of aspirin and dipyridamole on vascular DNA synthesis and intimal hyperplasia following deendothelialization. J Surg Res 1986 41 : 84 91.
33. Hermann A, Weber AA, Schror K. Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells. Thromb Res 2002 105 : 173 175.
34. von Hundelshausen P, Weber KSC, Huo Y, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001 103 : 1772 1777.
35. Evangelista V, Manarini S, Dell'Elba G, et al. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thromb Haemost 2005 94 : 568 577.
36. Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clin Pharmacol Ther 2002 71 : 176 185.
37. Klinkhardt U, Bauersachs R, Adams J, et al. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 2003 73 : 232 234.
38. Molero L, Lopez-Farre A, Mateos-Caceres PJ, et al. Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery. Br J Pharmacol 2005 146 : 419 424.
39. Ayral Y, Rauch U, Goldin-Lang P, et al. Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model. Cardiovasc Revasc Med 2007 8 : 183 188.
40. Yusuf S, Zhao F, Mehta SR, et al., for the Clopidogrel in Unstable Angina to Prevent Recurrent Events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 345 : 494 502.
41. Bhatt DL, Fox KA, Hacke W, et al., for the CHARISMA investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006 354 : 1706 1717.
42. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 2006 55 : 780 784.
43. Heitzer T, Rudolph V, Schwedhelm E, et al. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: Evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol 2006 26 : 1648 1652.
44. Harding SA, Sarma J, Din JN, et al. Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus. Heart 2006 92 : 1335 1337.